LMO2 and gene therapy for severe combined immunodeficiency.
Fischer
Alain
A
Abina
Salima Hacein-Bey
SH
Thrasher
Adrian
A
von Kalle
Christof
C
Cavazzana-Calvo
Marina
M
D000367:Age Factors; D005786:Gene Expression Regulation; D040181:Genetic Diseases, X-Linked / Q000235:genetics / Q000628:therapy; D015316:Genetic Therapy; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D009857:Oncogenes; D015375:Receptors, Interleukin-2 / Q000235:genetics / Q000378:metabolism; D016511:Severe Combined Immunodeficiency / Q000235:genetics* / Q000628:therapy; D013601:T-Lymphocytes / Q000502:physiology*; D014775:Virus Activation
D007376:Interleukin-2; D015375:Receptors, Interleukin-2